The credit ratings of Europe's NATO members are likely to suffer if they ramp up defence spending in line with U.S. President Donald Trump's demands although they might drive the region to jointly issue debt, ratings firm S&P Global has said. Despite almost doubling their defence expenditure since Russia annexed Ukraine's Crimea in 2014, European nations on average still spend below NATO's 2% of GDP guidelines, while the U.S. finances nearly two-thirds of NATO's military budget.
AMC Networks (NASDAQ:AMCX) Misses Q4 Revenue Estimates
Television broadcasting and production company AMC Networks (NASDAQ:AMCX) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 11.7% year on year to $599.3 million. Its non-GAAP profit of $0.64 per share was 38.8% below analysts’ consensus estimates.
HBL, S&P Global launch Pakistan's first manufacturing PMI
Pakistan's largest bank, HBL, and global financial information and analytics firm S&P Global have launched a new index to track the country's manufacturing sector, the companies said on Friday. Rising taxes and power tariffs have led to social unrest and hammered industries in Pakistan's $350 billion economy, as it navigates a tricky path to recovery under a $7 billion IMF program approved in September. The HBL S&P Global Purchasing Managers' Index will be a standardized economic indicator based on a survey of a diverse panel of industries.
Crypto Daybook Americas: Roses Are Red, Violets Are Blue, Inflation Is Hot, but Bitcoin Shines Through
Your day-ahead look for Feb. 14, 2025
Moderna’s (NASDAQ:MRNA) Q4 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations Significantly
Biotechnology company Moderna (NASDAQ:MRNA) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 65.6% year on year to $966 million. On the other hand, the company’s full-year revenue guidance of $2 billion at the midpoint came in 9.8% below analysts’ estimates. Its GAAP loss of $2.91 per share was 6.7% below analysts’ consensus estimates.
Cheap cigarettes will continue taking US market share, tobacco firm JTI predicts
Japan Tobacco International expects a shift towards cheaper cigarette brands in the United States to reach more than 40% of the market by 2027, its finance chief told Reuters. U.S. smokers have been swapping out brands such as Altria's Marlboro and British American Tobacco's (BAT) Newport, which have been raising prices for years, for less expensive brands as high inflation and interest rates stretch their wallets. BAT's U.S. cigarette volumes fell 10.1% last year in part due to this shift, it reported on Thursday, while Altria has also been losing market share.
Coinbase earnings get boost from the Trump sea change: What Wall Street is saying
Coinbase touts a pro-crypto market backdrop for a big quarter.
Why egg-flation could end up being a headache for the Fed: Morning Brief
Egg prices are both universal and easy to dismiss, as they're not used in "core" inflation. But they're important, almost psychologically, for consumers and the Fed.
Emerging economies most vulnerable to USAID elimination
War-torn countries, those with high levels of debt and U.S. allies such as Jordan have the most to lose if the United States Agency for International Development is dismantled, as proposed by the Trump administration. USAID has provided significant budgetary support in Ukraine and Jordan in particular, JPMorgan noted, and making up the lost support for healthcare, agriculture and infrastructure in those countries and elsewhere will be tough. JPMorgan said a permanent loss of USAID money was not enough to destabilise the economy in any of the roughly 30 emerging markets it tracks closely.
Intel’s Stock Is Soaring, but a Rescue Will Be Hard to Pull Off
President Trump’s domestic AI focus is a good sign for Intel, but easy fixes have proven elusive.